Trial intelligence / Profile preview

Metronidazole Gel and SMS Reminders for Gingivitis in Orthodontic Patients

NCT03508999Phase 4Completed

Sponsor
Aga Khan University
Start
May 2018
Primary completion
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of metronidazole in gingivitis (3 arms), sponsored by Aga Khan University. Primary endpoints: Bleeding Index at 4 weeks, Gingival Index at 4 weeks and 1 more. Started May 2018; status: completed.

02

Drugs

metronidazole
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT03508999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03508999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call